Cerecor Debt to Equity Ratio 2014-2018 | CERC

Current and historical debt to equity ratio values for Cerecor (CERC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cerecor debt/equity for the three months ending June 30, 2018 was 0.75.
Cerecor Annual Debt/Equity Ratio
2017 0.00
2016 11.37
2015 0.43
2014 3.58
2013 0.00
Cerecor Quarterly Debt/Equity Ratio
Q2 2018 0.80
Q1 2018 0.63
Q4 2017 0.00
Q3 2017 0.00
Q2 2017 0.19
Q1 2017 -3.51
Q4 2016 11.37
Q3 2016 5.44
Q2 2016 0.72
Q1 2016 0.54
Q4 2015 0.43
Q3 2015 -1.40
Q2 2015 0.00
Q1 2015 0.00
Q4 2014 0.00
Q3 2014 0.00
Q4 2013 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.156B $0.028B
Cerecor, Inc. is a biopharmaceutical company which focuses on the development of drugs for the treatment of patients with neurological and psychiatric disorders. The company's portfolio of clinical and preclinical candidates consists of CERC-301, CERC-501 and CERC-406. CERC-301; adjunctive antidepressant for the treatment of patients with major depressive disorder; CERC-501, for co-occurring psychiatric and substance use disorders and CERC-406, for the treatment of residual cognitive impairment symptoms. Cerecor, Inc. is headquartered in Baltimore, Maryland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.526B 15.10
Gilead Sciences (GILD) United States $95.774B 10.63
Biogen (BIIB) United States $68.271B 14.47
Celgene (CELG) United States $61.460B 12.27
Illumina (ILMN) United States $51.504B 64.53
Vertex Pharmaceuticals (VRTX) United States $45.132B 102.67
Regeneron Pharmaceuticals (REGN) United States $41.461B 23.31
Alexion Pharmaceuticals (ALXN) United States $27.182B 20.43
BioMarin Pharmaceutical (BMRN) United States $17.718B 0.00
Incyte (INCY) United States $14.296B 480.36
Seattle Genetics (SGEN) United States $12.306B 0.00
Sarepta Therapeutics (SRPT) United States $10.096B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.545B 0.00
Exact Sciences (EXAS) United States $9.101B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.881B 57.03
BeiGene (BGNE) Cayman Islands $8.791B 0.00
QIAGEN (QGEN) Netherlands $8.705B 28.46
Bluebird Bio (BLUE) United States $7.653B 0.00
Bio-Techne Corp (TECH) United States $7.499B 50.15
Alkermes (ALKS) Ireland $6.147B 0.00
Galapagos (GLPG) Belgium $5.897B 0.00
Ligand Pharmaceuticals (LGND) United States $5.575B 49.38
Exelixis (EXEL) United States $4.900B 15.96
Ultragenyx Pharmaceutical (RARE) United States $4.310B 0.00
Immunomedics (IMMU) United States $4.123B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.529B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.447B 0.00
Myriad Genetics (MYGN) United States $3.394B 37.98
Emergent Biosolutions (EBS) United States $3.316B 26.41
Array BioPharma (ARRY) United States $3.145B 0.00
Blueprint Medicines (BPMC) United States $3.143B 0.00
Horizon Pharma Public (HZNP) Ireland $3.141B 17.78
Ascendis Pharma (ASND) Denmark $2.824B 0.00
China Biologic Products (CBPO) China $2.708B 17.88
Acceleron Pharma (XLRN) United States $2.592B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.573B 0.00
Reata Pharmaceuticals (RETA) United States $2.538B 0.00
Repligen (RGEN) United States $2.527B 84.82
Medicines (MDCO) United States $2.479B 0.00
MyoKardia (MYOK) United States $2.473B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.469B 0.00
Genomic Health (GHDX) United States $2.465B 137.50
Halozyme Therapeutics (HALO) United States $2.460B 32.79
Akcea Therapeutics (AKCA) United States $2.319B 0.00
REGENXBIO (RGNX) United States $2.250B 35.35
Amicus Therapeutics (FOLD) United States $2.234B 0.00
AnaptysBio (ANAB) United States $2.168B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.130B 0.00
Spark Therapeutics (ONCE) United States $2.128B 0.00
Global Blood Therapeutics (GBT) United States $2.126B 0.00
Cambrex (CBM) United States $2.092B 16.77
Arena Pharmaceuticals (ARNA) United States $2.075B 0.00
G1 THERAPEUTICS (GTHX) United States $2.004B 0.00
Denali Therapeutics (DNLI) United States $1.936B 0.00
Allakos (ALLK) United States $1.907B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.888B 0.00
Mirati Therapeutics (MRTX) United States $1.854B 0.00
Puma Biotechnology (PBYI) United States $1.818B 0.00
Atara Biotherapeutics (ATRA) United States $1.814B 0.00
Solid Biosciences (SLDB) United States $1.738B 0.00
Myovant Sciences (MYOV) United Kingdom $1.725B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.709B 0.00
Clovis Oncology (CLVS) United States $1.696B 0.00
Rubius Therapeutics (RUBY) United States $1.618B 0.00
Aimmune Therapeutics (AIMT) United States $1.611B 0.00
Editas Medicine (EDIT) United States $1.582B 0.00
Insmed (INSM) United States $1.565B 0.00
Sangamo Therapeutics (SGMO) United States $1.561B 0.00
Innoviva (INVA) United States $1.545B 9.91
Biohaven Pharmaceutical Holding (BHVN) United States $1.495B 0.00
Audentes Therapeutics (BOLD) United States $1.470B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.450B 0.00
WAVE Life Sciences (WVE) Singapore $1.441B 0.00
UniQure (QURE) Netherlands $1.432B 0.00
Intellia Therapeutics (NTLA) United States $1.382B 0.00
IMMURON LTD (IMRN) Australia $1.371B 0.00
DBV Technologies (DBVT) France $1.371B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.370B 0.00
Lion Biotechnologies (IOVA) United States $1.305B 0.00
Retrophin (RTRX) United States $1.194B 0.00
NeoGenomics (NEO) United States $1.192B 208.57
Viking Therapeutics (VKTX) United States $1.192B 0.00
Cellectis (CLLS) France $1.190B 0.00
Intra-Cellular Therapies (ITCI) United States $1.160B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.142B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.138B 0.00
Coherus BioSciences (CHRS) United States $1.119B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.117B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.114B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.088B 0.00
Athenex (ATNX) United States $1.079B 0.00
AVROBIO (AVRO) United States $1.077B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.068B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.029B 1965.00
Apellis Pharmaceuticals (APLS) United States $1.014B 0.00
Geron (GERN) United States $1.012B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.009B 0.00
Aptinyx (APTX) United States $0.928B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.906B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
Cara Therapeutics (CARA) United States $0.872B 0.00
Acorda Therapeutics (ACOR) United States $0.855B 17.82
CytomX Therapeutics (CTMX) United States $0.841B 0.00
Amarin (AMRN) Ireland $0.833B 0.00
Heska (HSKA) United States $0.825B 71.02
InflaRx (IFRX) Germany $0.796B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.759B 0.00
Dynavax Technologies (DVAX) United States $0.748B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.743B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.726B 0.00
UNITY Biotechnology (UBX) $0.721B 0.00
Epizyme (EPZM) United States $0.719B 0.00
Fate Therapeutics (FATE) United States $0.714B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.714B 0.00
Abeona Therapeutics (ABEO) United States $0.662B 0.00
UROGEN PHARMA (URGN) Israel $0.654B 0.00
Verastem (VSTM) United States $0.650B 0.00
Scholar Rock Holding (SRRK) United States $0.638B 0.00
ObsEva SA (OBSV) Switzerland $0.637B 0.00
Kura Oncology (KURA) United States $0.636B 0.00
ANI Pharmaceuticals (ANIP) United States $0.631B 12.49
Arcus Biosciences (RCUS) United States $0.623B 0.00
MiMedx (MDXG) United States $0.611B 26.19
Mesoblast (MESO) Australia $0.605B 0.00
Vericel (VCEL) United States $0.600B 0.00
Anika Therapeutics (ANIK) United States $0.591B 24.85
Replimune (REPL) United States $0.575B 0.00
BeyondSpring (BYSI) United States $0.568B 0.00
Zealand Pharma (ZEAL) Denmark $0.562B 0.00
Novavax (NVAX) United States $0.547B 0.00
AC Immune SA (ACIU) Switzerland $0.547B 0.00
Stemline Therapeutics (STML) United States $0.541B 0.00
Prothena (PRTA) Ireland $0.532B 0.00
Sorrento Therapeutics (SRNE) United States $0.531B 91.00
GTx (GTXI) United States $0.527B 0.00
Arbutus Biopharma (ABUS) Canada $0.518B 0.00
Senesco Technologies (ELOX) United States $0.516B 0.00
Five Prime Therapeutics (FPRX) United States $0.507B 0.00
Aduro Biotech (ADRO) United States $0.506B 0.00
Zymeworks (ZYME) Canada $0.490B 0.00
RA PHARMCTL INC (RARX) United States $0.467B 0.00
MediciNova (MNOV) United States $0.463B 0.00
Cytokineticsorporated (CYTK) United States $0.456B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.452B 0.00
Merus (MRUS) Netherlands $0.446B 0.00
Inovio Pharmaceuticals (INO) United States $0.441B 0.00
Kindred Biosciences (KIN) United States $0.438B 0.00
Evelo Biosciences (EVLO) United States $0.430B 0.00
Sinovac Biotech (SVA) China $0.426B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.426B 0.00
Eidos Therapeutics (EIDX) United States $0.420B 0.00
Syros Pharmaceuticals (SYRS) United States $0.415B 0.00
Albireo Pharma (ALBO) United States $0.400B 0.00
Osiris Therapeutics (OSIR) United States $0.397B 0.00
ResTORbio (TORC) United States $0.394B 0.00
Magenta Therapeutics (MGTA) United States $0.382B 0.00
Kadmon Holdings (KDMN) United States $0.378B 0.00
Kezar Life Sciences (KZR) United States $0.370B 0.00
Unum Therapeutics (UMRX) United States $0.367B 0.00
Adverum Biotechnologies (ADVM) United States $0.367B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.361B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.347B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.346B 0.00
PDL BioPharma (PDLI) United States $0.345B 4.84
AVEO Pharmaceuticals (AVEO) United States $0.342B 0.00
Synlogic (SYBX) United States $0.341B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.328B 0.00
Selecta Biosciences (SELB) United States $0.321B 0.00
MeiraGTx Holdings (MGTX) United States $0.320B 0.00
Seres Therapeutics (MCRB) United States $0.307B 0.00
Celcuity (CELC) United States $0.302B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.302B 0.00
ADMA Biologics Inc (ADMA) United States $0.301B 0.00
BioTime (BTX) United States $0.294B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.292B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.290B 0.00
Liquidia Technologies (LQDA) United States $0.285B 0.00
Mersana Therapeutics (MRSN) United States $0.280B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.276B 0.00
Celyad SA (CYAD) Belgium $0.272B 0.00
Kala Pharmaceuticals (KALA) United States $0.263B 0.00
MannKind (MNKD) United States $0.263B 0.00
Athersys (ATHX) United States $0.259B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.257B 0.00
Axovant Sciences (AXON) United Kingdom $0.255B 0.00
Menlo Therapeutics (MNLO) United States $0.253B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.250B 0.00
NantKwest (NK) United States $0.245B 0.00
TOCAGEN INC (TOCA) United States $0.243B 0.00
Kamada (KMDA) Israel $0.242B 18.75
Allena Pharmaceuticals (ALNA) United States $0.230B 0.00
Agenus (AGEN) United States $0.227B 0.00
Idera Pharmaceuticals (IDRA) United States $0.225B 0.00
Palatin Technologies (PTN) United States $0.208B 8.58
Enzo Biochem (ENZ) United States $0.207B 0.00
Clearside Biomedical (CLSD) United States $0.206B 0.00
ChromaDex (CDXC) United States $0.201B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.199B 0.00
Compugen (CGEN) Israel $0.195B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.187B 0.00
Cue Biopharma (CUE) United States $0.186B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Constellation Pharmaceuticals (CNST) United States $0.180B 0.00
Signal Genetics (MGEN) United States $0.177B 0.00
Cohbar (CWBR) United States $0.175B 0.00
Mustang Bio (MBIO) United States $0.174B 0.00
Monster Digital (INNT) United States $0.174B 0.00
Krystal Biotech (KRYS) United States $0.171B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.171B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.163B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.162B 0.00
Eleven Biotherapeutics (SESN) United States $0.162B 0.00
BioDelivery Sciences (BDSI) United States $0.161B 0.00
Pfenex (PFNX) United States $0.158B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.158B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.151B 0.00
Pluristem Therapeutics (PSTI) Israel $0.150B 0.00
OVID THERAPEUTC (OVID) United States $0.144B 0.00
Provention Bio (PRVB) United States $0.144B 0.00
Intec Pharma (NTEC) Israel $0.143B 0.00
Checkpoint Therapeutics (CKPT) United States $0.141B 0.00
PSivida (EYPT) United States $0.135B 0.00
XOMA (XOMA) United States $0.135B 14.22
Organovo Holdings (ONVO) United States $0.132B 0.00
Tapimmune (TPIV) United States $0.127B 0.00
Motif Bio Plc (MTFB) United States $0.126B 0.00
Trevena (TRVN) United States $0.124B 0.00
BioXcel Therapeutics (BTAI) United States $0.119B 0.00
VBI Vaccines (VBIV) United States $0.118B 0.00
Aptevo Therapeutics (APVO) United States $0.115B 0.00
Cidara Therapeutics (CDTX) United States $0.115B 0.00
Catalyst Biosciences (CBIO) United States $0.115B 0.00
Anavex Life Sciences (AVXL) United States $0.113B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.108B 0.00
Cel-Sci (CVM) United States $0.103B 0.00
Leap Therapeutics (LPTX) United States $0.102B 0.00
ARIDIS PHARMACT (ARDS) United States $0.101B 0.00
Alcobra (ARCT) United States $0.101B 0.00
Vaccinex (VCNX) United States $0.100B 0.00
XBiotech (XBIT) United States $0.099B 0.00
Neothetics (EVFM) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.096B 0.00
Aptose Biosciences (APTO) Canada $0.093B 0.00
Protalix BioTherapeutics (PLX) Israel $0.091B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.090B 0.00
Ophthotech (OPHT) United States $0.087B 0.57
NewLink Genetics (NLNK) United States $0.087B 0.00
Prima BioMed (IMMP) Australia $0.084B 0.00
Axsome Therapeutics (AXSM) United States $0.083B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Sophiris Bio (SPHS) United States $0.081B 0.00
VolitionRX (VNRX) Singapore $0.080B 0.00
Evogene (EVGN) Israel $0.080B 0.00
Applied Genetic Technologies (AGTC) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.078B 0.00
Asterias Biotherapeutics (AST) United States $0.078B 0.00
Cocrystal Pharma (COCP) United States $0.076B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.076B 0.00
Alimera Sciences (ALIM) United States $0.075B 0.00
Chiasma (CHMA) United States $0.074B 0.00
Novelion Therapeutics (NVLN) Canada $0.074B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.071B 0.00
Oncolytics Biotech (ONCY) Canada $0.070B 0.00
OncoSec Medical (ONCS) United States $0.070B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
TRACON Pharmaceuticals (TCON) United States $0.066B 0.00
Oncobiologics (ONS) United States $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.065B 0.00
Caladrius Biosciences (CLBS) United States $0.059B 0.00
CorMedix Inc (CRMD) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.058B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.058B 0.00
Curis (CRIS) United States $0.055B 0.00
VIVUS (VVUS) United States $0.053B 0.00
Aileron Therapeutics (ALRN) United States $0.050B 0.00
Celsion (CLSN) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.047B 0.00
Eyenovia (EYEN) United States $0.046B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
Advaxis (ADXS) United States $0.044B 0.00
AZURRX BIOPHARM (AZRX) United States $0.043B 0.00
BioPharmX (BPMX) United States $0.041B 0.00
Proteon Therapeutics (PRTO) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
GENPREX INC (GNPX) United States $0.037B 0.00
CytRx (CYTR) United States $0.035B 0.00
VistaGen Therapeutics (VTGN) United States $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.034B 0.00
Gemphire Therapeutics (GEMP) United States $0.033B 0.00
Vical (VICL) United States $0.030B 0.00
VTv Therapeutics (VTVT) United States $0.029B 0.00
Soligenix (SNGX) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 54.39
Cellect Biotechnology (APOP) Israel $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Arsanis (ASNS) United States $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
RestorGenex (DFFN) United States $0.022B 0.00
Galena Biopharma (SLS) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Histogenics (HSGX) United States $0.016B 0.00
Neuralstem (CUR) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
AmpliPhi Biosciences (APHB) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 5.26
Vital Therapies (VTL) United States $0.014B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.009B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Oragenics (OGEN) United States $0.006B 0.00
Aytu Bioscience (AYTU) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00